The Emerging Role and Clinical Impact of Vitamin D Supplementation in Breast Cancer Patients Undergoing Chemotherapy: A Systematic Review
Open Access
- 11 August 2026
- journal article
- review article
- Published by Charles University in Prague, Karolinum Press in Acta Medica (Hradec Kralove, Czech Republic)
- Vol. 69 (2) , 55-64
Abstract
Introduction: Breast cancer is the most common cancer in women and is often diagnosed at an advanced stage. Chemotherapy plays a crucial role in disease control but is limited by toxicity and response variability. Vitamin D, with its biological functions and the high prevalence of deficiency in patients, has potential as an adjuvant therapy to improve treatment response and clinical outcomes. Objective: To integrate existing evidence on the role of vitamin D supplementation in breast cancer patients undergoing chemotherapy, focusing on its impact on treatment response and clinical outcomes. Methods: This systematic review followed PRISMA guidelines and included RCTs, cohort, and case-control studies evaluating vitamin D supplementation in adult women with breast cancer undergoing chemotherapy. A comprehensive search across five databases up to June 2025 was conducted, applying the pre-established PICOS criteria, with filtering, data extraction, and quality assessment performed. This systematic review has been prospectively registered in the PROSPERO database (CRD420251142938). Results: This systematic review identified six eligible studies involving breast cancer patients undergoing chemotherapy, with interventions ranging from low- to high-dose vitamin D, either alone or in combination with synbiotics. Vitamin D supplementation in breast cancer patients undergoing chemotherapy has been associated with improved clinical outcomes, including enhanced nutritional status, reduced inflammatory and cardiotoxic biomarkers, and increased pathological complete response (pCR) and disease-free survival (DFS). Conclusion: Vitamin D supplementation during chemotherapy shows potential benefits in breast cancer patients, but large-scale standardized trials with long-term follow-up are needed to confirm its impact on survival outcomes.Keywords
This publication has 34 references indexed in Scilit:
- Vitamin D Supplementation During Neoadjuvant Chemotherapy for Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical TrialWorld Journal of Surgery, 2025
- Global patterns and trends in breast cancer incidence and mortality across 185 countriesNature Medicine, 2025
- Vitamin D and the risk for cancer: A molecular analysisBiochemical Pharmacology, 2022
- The Cardioprotective Effect of Vitamin D in Breast Cancer Patients Receiving Adjuvant Doxorubicin Based ChemotherapyClinical Breast Cancer, 2022
- Vitamin D and Breast Cancer: Mechanistic UpdateJBMR Plus, 2021
- The role of chemotherapy in treatment of advanced breast cancer: an overview for clinical practiceCritical Reviews in Oncology/Hematology, 2020
- Use and effects of oral nutritional supplements in patients with cancerNutrition, 2019
- Cancer-associated malnutritionEuropean Journal of Clinical Nutrition, 2018
- Exploring vitamin D metabolism and function in cancerExperimental & Molecular Medicine, 2018
- Improved Clinical Outcomes Associated With Vitamin D Supplementation During Adjuvant Chemotherapy in Patients With HER2+ Nonmetastatic Breast CancerClinical Breast Cancer, 2015